| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | - | 760.0 | 2053.0 | 240.0 | 5.0 | 3058 |
| 1 | - | - | - | - | - | - | 6.0 | 6.0 | - | - | 12 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 3 |
| 1 | 2 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 236 |
| 1 | 1117 |
| Number of post synapses: | 3058 |
| Number of pre synapses: | 12 |
| Number of output connections: | 26 |
| Coverage factor: | 1.0 |
| Columnar completeness: | 0.44 |
| Area completeness: | 0.62 |
| Cell size (columns): | 389 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#MeVP23 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Pm9 (R) | GABA | 400 | 400.0 | 13.2% | 13.2% |
| 1 | TmY21 (R) | ACh | 380 | 380.0 | 12.6% | 25.8% |
| 2 | MeLo14 (R) | Glu | 255 | 255.0 | 8.4% | 34.2% |
| 3 | Pm12 (R) | Glu | 216 | 216.0 | 7.1% | 41.4% |
| 4 | MeVC4b (L) | ACh | 183 | 183.0 | 6.1% | 47.4% |
| 5 | C3 (R) | GABA | 180 | 180.0 | 6.0% | 53.4% |
| 6 | Pm8 (R) | GABA | 171 | 171.0 | 5.7% | 59.0% |
| 7 | OLVC5 (R) | ACh | 144 | 144.0 | 4.8% | 63.8% |
| 8 | TmY17 (R) | ACh | 124 | 124.0 | 4.1% | 67.9% |
| 9 | MeVC4a (L) | ACh | 82 | 82.0 | 2.7% | 70.6% |
| 10 | Mi10 (R) | ACh | 77 | 77.0 | 2.5% | 73.1% |
| 11 | Tm38 (R) | ACh | 63 | 63.0 | 2.1% | 75.2% |
| 12 | MeVPMe1 (L) | Glu | 55 | 55.0 | 1.8% | 77.1% |
| 13 | TmY10 (R) | ACh | 55 | 55.0 | 1.8% | 78.9% |
| 14 | MeLo8 (R) | GABA | 53 | 53.0 | 1.8% | 80.6% |
| 15 | Tm5Y (R) | ACh | 43 | 43.0 | 1.4% | 82.0% |
| 16 | Tm20 (R) | ACh | 32 | 32.0 | 1.1% | 83.1% |
| 17 | Y14 (R) | Glu | 32 | 32.0 | 1.1% | 84.2% |
| 18 | TmY14 (R) | Glu | 29 | 29.0 | 1.0% | 85.1% |
| 19 | TmY5a (R) | Glu | 25 | 25.0 | 0.8% | 85.9% |
| 20 | TmY20 (R) | ACh | 24 | 24.0 | 0.8% | 86.7% |
| 21 | LPT54 (R) | ACh | 17 | 17.0 | 0.6% | 87.3% |
| 22 | Pm_unclear (R) | GABA | 17 | 17.0 | 0.6% | 87.9% |
| 23 | MeVPMe1 (R) | Glu | 16 | 16.0 | 0.5% | 88.4% |
| 24 | TmY9b (R) | ACh | 15 | 15.0 | 0.5% | 88.9% |
| 25 | MeVC1 (L) | ACh | 14 | 14.0 | 0.5% | 89.4% |
| 26 | Cm8 (R) | GABA | 13 | 13.0 | 0.4% | 89.8% |
| 27 | MeVC25 (R) | Glu | 12 | 12.0 | 0.4% | 90.2% |
| 28 | Pm6 (R) | GABA | 12 | 12.0 | 0.4% | 90.6% |
| 29 | Pm10 (R) | GABA | 11 | 11.0 | 0.4% | 90.9% |
| 30 | Tm16 (R) | ACh | 11 | 11.0 | 0.4% | 91.3% |
| 31 | Tm26 (R) | ACh | 10 | 10.0 | 0.3% | 91.6% |
| 32 | Tm29 (R) | Glu | 10 | 10.0 | 0.3% | 92.0% |
| 33 | Tm3 (R) | ACh | 10 | 10.0 | 0.3% | 92.3% |
| 34 | MeVP11 (R) | ACh | 9 | 9.0 | 0.3% | 92.6% |
| 35 | Mi4 (R) | GABA | 9 | 9.0 | 0.3% | 92.9% |
| 36 | Cm3 (R) | GABA | 8 | 8.0 | 0.3% | 93.2% |
| 37 | T2a (R) | ACh | 8 | 8.0 | 0.3% | 93.4% |
| 38 | Cm5 (R) | GABA | 7 | 7.0 | 0.2% | 93.7% |
| 39 | Cm7 (R) | Glu | 7 | 7.0 | 0.2% | 93.9% |
| 40 | MeVP3 (R) | ACh | 7 | 7.0 | 0.2% | 94.1% |
| 41 | Mi9 (R) | Glu | 7 | 7.0 | 0.2% | 94.3% |
| 42 | Pm1 (R) | GABA | 7 | 7.0 | 0.2% | 94.6% |
| 43 | Pm4 (R) | GABA | 7 | 7.0 | 0.2% | 94.8% |
| 44 | Cm13 (R) | Glu | 6 | 6.0 | 0.2% | 95.0% |
| 45 | Cm34 (R) | Glu | 6 | 6.0 | 0.2% | 95.2% |
| 46 | Mi17 (R) | GABA | 6 | 6.0 | 0.2% | 95.4% |
| 47 | Tm4 (R) | ACh | 6 | 6.0 | 0.2% | 95.6% |
| 48 | TmY13 (R) | ACh | 6 | 6.0 | 0.2% | 95.8% |
| 49 | Y13 (R) | Glu | 6 | 6.0 | 0.2% | 96.0% |
| 50 | Tm1 (R) | ACh | 5 | 5.0 | 0.2% | 96.2% |
| 51 | Y11 (R) | Glu | 5 | 5.0 | 0.2% | 96.3% |
| 52 | 5-HTPMPV03 (L) | 5HT | 4 | 4.0 | 0.1% | 96.5% |
| 53 | Pm2b (R) | GABA | 4 | 4.0 | 0.1% | 96.6% |
| 54 | T2 (R) | ACh | 4 | 4.0 | 0.1% | 96.7% |
| 55 | Tm31 (R) | Glu | 4 | 4.0 | 0.1% | 96.9% |
| 56 | Y12 (R) | Glu | 4 | 4.0 | 0.1% | 97.0% |
| 57 | 5-HTPMPV03 (R) | 5HT | 3 | 3.0 | 0.1% | 97.1% |
| 58 | Cm24 (R) | Glu | 3 | 3.0 | 0.1% | 97.2% |
| 59 | MeLo9 (R) | Glu | 3 | 3.0 | 0.1% | 97.3% |
| 60 | MeVC3 (L) | ACh | 3 | 3.0 | 0.1% | 97.4% |
| 61 | OA-AL2i1 (R) | OA | 3 | 3.0 | 0.1% | 97.5% |
| 62 | Pm3 (R) | GABA | 3 | 3.0 | 0.1% | 97.6% |
| 63 | Pm7 (R) | GABA | 3 | 3.0 | 0.1% | 97.7% |
| 64 | Y3 (R) | ACh | 3 | 3.0 | 0.1% | 97.8% |
| 65 | Cm31a (R) | GABA | 2 | 2.0 | 0.1% | 97.9% |
| 66 | MeLo11 (R) | Glu | 2 | 2.0 | 0.1% | 97.9% |
| 67 | MeLo3a (R) | ACh | 2 | 2.0 | 0.1% | 98.0% |
| 68 | MeLo7 (R) | ACh | 2 | 2.0 | 0.1% | 98.0% |
| 69 | MeVC21 (R) | Glu | 2 | 2.0 | 0.1% | 98.1% |
| 70 | MeVP51 (R) | Glu | 2 | 2.0 | 0.1% | 98.2% |
| 71 | MeVP64 (R) | Glu | 2 | 2.0 | 0.1% | 98.2% |
| 72 | Mi2 (R) | Glu | 2 | 2.0 | 0.1% | 98.3% |
| 73 | OA-AL2i4 (R) | OA | 2 | 2.0 | 0.1% | 98.4% |
| 74 | OA-ASM1 (L) | OA | 2 | 2.0 | 0.1% | 98.4% |
| 75 | Pm13 (R) | Glu | 2 | 2.0 | 0.1% | 98.5% |
| 76 | Pm2a (R) | GABA | 2 | 2.0 | 0.1% | 98.6% |
| 77 | Tm32 (R) | Glu | 2 | 2.0 | 0.1% | 98.6% |
| 78 | Tm37 (R) | Glu | 2 | 2.0 | 0.1% | 98.7% |
| 79 | Tm40 (R) | ACh | 2 | 2.0 | 0.1% | 98.8% |
| 80 | Tm5a (R) | ACh | 2 | 2.0 | 0.1% | 98.8% |
| 81 | TmY19a (R) | GABA | 2 | 2.0 | 0.1% | 98.9% |
| 82 | aMe17b (R) | GABA | 1 | 1.0 | 0.0% | 98.9% |
| 83 | aMe17e (R) | Glu | 1 | 1.0 | 0.0% | 99.0% |
| 84 | Cm17 (R) | GABA | 1 | 1.0 | 0.0% | 99.0% |
| 85 | Cm4 (R) | Glu | 1 | 1.0 | 0.0% | 99.0% |
| 86 | Cm6 (R) | GABA | 1 | 1.0 | 0.0% | 99.1% |
| 87 | Cm9 (R) | Glu | 1 | 1.0 | 0.0% | 99.1% |
| 88 | Dm12 (R) | Glu | 1 | 1.0 | 0.0% | 99.1% |
| 89 | DNp30 (L) | unclear | 1 | 1.0 | 0.0% | 99.2% |
| 90 | LC10_unclear (R) | ACh | 1 | 1.0 | 0.0% | 99.2% |
| 91 | MeLo1 (R) | ACh | 1 | 1.0 | 0.0% | 99.2% |
| 92 | MeLo10 (R) | Glu | 1 | 1.0 | 0.0% | 99.3% |
| 93 | MeVC11 (L) | ACh | 1 | 1.0 | 0.0% | 99.3% |
| 94 | MeVC2 (L) | ACh | 1 | 1.0 | 0.0% | 99.3% |
| 95 | MeVC22 (R) | Glu | 1 | 1.0 | 0.0% | 99.4% |
| 96 | MeVP28 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
| 97 | MeVP34 (R) | unclear | 1 | 1.0 | 0.0% | 99.4% |
| 98 | MeVP53 (R) | GABA | 1 | 1.0 | 0.0% | 99.5% |
| 99 | MeVPLo1 (R) | Glu | 1 | 1.0 | 0.0% | 99.5% |
| 100 | Mi14 (R) | Glu | 1 | 1.0 | 0.0% | 99.5% |
| 101 | Mi19 (R) | 5HT | 1 | 1.0 | 0.0% | 99.6% |
| 102 | OA-AL2i2 (R) | OA | 1 | 1.0 | 0.0% | 99.6% |
| 103 | OA-AL2i3 (R) | OA | 1 | 1.0 | 0.0% | 99.6% |
| 104 | OA-ASM1 (R) | OA | 1 | 1.0 | 0.0% | 99.7% |
| 105 | PLP069 (R) | unclear | 1 | 1.0 | 0.0% | 99.7% |
| 106 | PLP211 (R) | unclear | 1 | 1.0 | 0.0% | 99.7% |
| 107 | T3 (R) | ACh | 1 | 1.0 | 0.0% | 99.8% |
| 108 | Tm12 (R) | ACh | 1 | 1.0 | 0.0% | 99.8% |
| 109 | Tm30 (R) | GABA | 1 | 1.0 | 0.0% | 99.8% |
| 110 | Tm39 (R) | ACh | 1 | 1.0 | 0.0% | 99.9% |
| 111 | Tm5b (R) | ACh | 1 | 1.0 | 0.0% | 99.9% |
| 112 | TmY16 (R) | Glu | 1 | 1.0 | 0.0% | 99.9% |
| 113 | TmY4 (R) | ACh | 1 | 1.0 | 0.0% | 100.0% |
| 114 | TmY9a (R) | ACh | 1 | 1.0 | 0.0% | 100.0% |
| instance | NT | total connections | connections /#MeVP23 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe17b (R) | GABA | 15 | 15.0 | 31.2% | 31.2% |
| 1 | TmY10 (R) | ACh | 4 | 4.0 | 8.3% | 39.6% |
| 2 | MeVPLo1 (R) | Glu | 3 | 3.0 | 6.2% | 45.8% |
| 3 | MeVPOL1 (R) | ACh | 2 | 2.0 | 4.2% | 50.0% |
| 4 | Tm16 (R) | ACh | 2 | 2.0 | 4.2% | 54.2% |
| 5 | Tm5Y (R) | ACh | 2 | 2.0 | 4.2% | 58.3% |
| 6 | aMe17a (R) | Glu | 1 | 1.0 | 2.1% | 60.4% |
| 7 | C3 (R) | GABA | 1 | 1.0 | 2.1% | 62.5% |
| 8 | Cm17 (R) | GABA | 1 | 1.0 | 2.1% | 64.6% |
| 9 | l-LNv (R) | unclear | 1 | 1.0 | 2.1% | 66.7% |
| 10 | LPT54 (R) | ACh | 1 | 1.0 | 2.1% | 68.8% |
| 11 | MeLo1 (R) | ACh | 1 | 1.0 | 2.1% | 70.8% |
| 12 | MeLo7 (R) | ACh | 1 | 1.0 | 2.1% | 72.9% |
| 13 | MeVC4b (L) | ACh | 1 | 1.0 | 2.1% | 75.0% |
| 14 | MeVP3 (R) | ACh | 1 | 1.0 | 2.1% | 77.1% |
| 15 | MeVP58 (R) | unclear | 1 | 1.0 | 2.1% | 79.2% |
| 16 | MeVPMe2 (R) | Glu | 1 | 1.0 | 2.1% | 81.3% |
| 17 | Mi18 (R) | GABA | 1 | 1.0 | 2.1% | 83.3% |
| 18 | Mi4 (R) | GABA | 1 | 1.0 | 2.1% | 85.4% |
| 19 | PLP069 (R) | unclear | 1 | 1.0 | 2.1% | 87.5% |
| 20 | PLP211 (R) | unclear | 1 | 1.0 | 2.1% | 89.6% |
| 21 | Tm31 (R) | Glu | 1 | 1.0 | 2.1% | 91.7% |
| 22 | Tm32 (R) | Glu | 1 | 1.0 | 2.1% | 93.8% |
| 23 | Tm34 (R) | Glu | 1 | 1.0 | 2.1% | 95.8% |
| 24 | Tm35 (R) | Glu | 1 | 1.0 | 2.1% | 97.9% |
| 25 | TmY21 (R) | ACh | 1 | 1.0 | 2.1% | 100.0% |